Business / Finance

RSS

Avantra is now Courtagen Life Sciences

Avantra Biosciences Corporation today announced that effective immediately it is changing its name to Courtagen Life Sciences, Inc. The company will continue to use the Avantra name for their proteomics portfolio, which includes the Avantra Biomarker System.

30 Aug 2011

EMD Millipore acquires Amnis

Amnis Corporation, a manufacturer of advanced cell imaging systems, today announced that the company has been acquired by EMD Millipore, the Life Science division of Merck KGaA of Germany.

30 Aug 2011

RaySearch Laboratories reports net sales of SEK 47.6 M for January 1 - June 30, 2011

RaySearch Laboratories: JANUARY 1 - JUNE 30, 2011. Net sales for the period totaled SEK 47.6 M.

30 Aug 2011

UHC Supply Chain helps University of Iowa Hospitals and Clinics to save $14M in 18 months

A supply chain strategy built on excellence in customer service and a partnership with UHC Supply Chain has helped UHC member University of Iowa Hospitals and Clinics initiate 35 projects that saved more than $14 million in 18 months.

30 Aug 2011

Adimab initiates independent collaborations with Biogen Idec and Novo Nordisk

Adimab, LLC, a technology leader in the discovery of fully human antibodies, today announced the initiation of two independent collaborations with Biogen Idec and Novo Nordisk. Over the past two years, Adimab has established collaborations with multiple leading pharmaceutical companies, including: Merck, Roche, Novartis, Pfizer, Eli Lilly, Genentech, Human Genome Sciences, and now Biogen Idec and Novo Nordisk.

29 Aug 2011

BioAmber selects Sarnia as location for first North American biosuccinic acid plant

BioAmber Inc., through its subsidiary Bluewater Biochemicals has selected Sarnia, Ontario, Canada as the location for its first North American biosuccinic acid plant. The Sarnia plant will have an initial capacity of 17,000 MT and will be commissioned in 2013. Permitting work for the plant was initiated in June 2011. BioAmber currently produces and sells biobased succinic acid at a 3,000 MT capacity plant in France.

29 Aug 2011

Covalon reports net loss of $1,207,559 for third quarter 2011

Mr. Brian Pedlar, President and CEO of Covalon Technologies Ltd., an advanced medical technologies company, is pleased to provide the following update. "We are very pleased that Covalon continues to make excellent progress in meeting its objectives.

29 Aug 2011

Affinium closes $15 million financing round

Affinium Pharmaceuticals announced today the closing of its $15 million financing. Investors participating in the financing include all three of Affinium's Series A investors, SV Life Sciences, Genesis Capital Partners and Forward Ventures, along with the addition of the Ontario Emerging Technologies Fund (OETF) to the syndicate.

29 Aug 2011

Health Robotics first half gross revenues increase 42% to $9.4 million

Health Robotics today announced 1H2011 financial results, delivering record levels of revenues, gross margins and net earnings for a six-month period. Gross Revenues reached $9.4 million (€6.5M) and Gross Margins were $7.3 million (€5M), respectively 42% and 72% increases over-year-ago period; both increases were directly linked to the significantly improved performance resulting from Health Robotics' greater dependence on its own European and American based staff, replacing its prior, non-functioning indirect distribution and service channels.

29 Aug 2011

European infusion therapy device market to reach €533 million by 2017: New report

According to a new report by iData Research, the leading global authority in medical device market research, the European infusion therapy device market, which includes needleless connectors, infusion pumps and intravenous (IV) sets, was valued at an estimated €443 million in 2010.

29 Aug 2011

SQI Diagnostics third quarter net loss increases to $2,691,000

SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the third quarter ended June 30, 2011.

29 Aug 2011

Infrared Systems completes several internal projects, discusses corporate strategies

Infrared Systems International announces the completion of several internal projects and discusses corporate strategies for continued success.

29 Aug 2011

QIAGEN acquires Cellestis

QIAGEN N.V. today announced that its acquisition of all the ordinary shares in Cellestis Limited by a way of a scheme of arrangement has been implemented.

From QIAGEN Manchester Limited 29 Aug 2011

QLI, author of 'The Steve Jobs Way' sign licensing agreement for new training program

Quantum Learning, Inc. (QLI), a research-based provider of advanced sales and marketing training programs, and Jay Elliot, author of the book "The Steve Jobs Way" http://www.thestevejobsway.com, jointly announced today a licensing agreement.

29 Aug 2011

Triad Senior Living announces acquisition of University Village retirement community

Triad Senior Living, Inc., a Dallas based senior housing provider with offices now in Tulsa, announced the successful acquisition of the University Village retirement community in Tulsa.

29 Aug 2011

Victhom second quarter revenues up 30.4%

Victhom Human Bionics Inc. today reported its second quarter 2011 financial results.

26 Aug 2011

BioSpec Global Solutions commences talks with U.K., Chinese distributors for TOGS product lines

ICBS Ltd., announced today that partner BioSpec Global Solutions Inc. has opened talks with a U.K. , and Chinese distributors for the TOGS product lines.

26 Aug 2011

Varian enters accelerated share repurchase agreement

Varian Medical Systems today announced that it has entered into an agreement with Bank of America, N.A. to repurchase $250 million of its common stock under an accelerated share repurchase program. Concurrently, the company amended its revolving credit facility with Bank of America, N.A. to increase its borrowing capacity from $225 million to $300 million.

26 Aug 2011

BioPhausia to sell generics business to Bluefish Pharmaceuticals

Medivir AB, is an expanding, research-based specialty pharmaceutical company focusing on infectious diseases. Medivir reports that on 25 August, BioPhausia AB reached an agreement to sell its generics business in the form of subsidiary BMM Pharma AB to Bluefish Pharmaceuticals AB for SEK 26 m plus the value of inventories, some SEK 12 m.

26 Aug 2011

Essilor introduces first high performance anti-fogging lenses

Essilor today announced the launch of Optifog, the first high-performance anti-fogging lenses, in response to high consumer demand. This new category of lenses represents a major technological breakthrough in keeping with the long tradition of innovation at Essilor.

26 Aug 2011

Business / Finance

Avantra is now Courtagen Life Sciences

EMD Millipore acquires Amnis

RaySearch Laboratories reports net sales of SEK 47.6 M for January 1 - June 30, 2011

UHC Supply Chain helps University of Iowa Hospitals and Clinics to save $14M in 18 months

Adimab initiates independent collaborations with Biogen Idec and Novo Nordisk

BioAmber selects Sarnia as location for first North American biosuccinic acid plant

Covalon reports net loss of $1,207,559 for third quarter 2011

Affinium closes $15 million financing round

Health Robotics first half gross revenues increase 42% to $9.4 million

European infusion therapy device market to reach €533 million by 2017: New report

SQI Diagnostics third quarter net loss increases to $2,691,000

Infrared Systems completes several internal projects, discusses corporate strategies

QIAGEN acquires Cellestis

QLI, author of 'The Steve Jobs Way' sign licensing agreement for new training program

Triad Senior Living announces acquisition of University Village retirement community

Victhom second quarter revenues up 30.4%

BioSpec Global Solutions commences talks with U.K., Chinese distributors for TOGS product lines

Varian enters accelerated share repurchase agreement

BioPhausia to sell generics business to Bluefish Pharmaceuticals

Essilor introduces first high performance anti-fogging lenses

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Latest News